Market Inference Overview -- RYAN Stock

By Kim Brooks • Thursday, July 06 15:07 • Permanent Link

Mid-cap Finance company Ryan Specialty has moved 0.8% so far today on a volume of 449,529, compared to its average of 683,550. In contrast, the S&P 500 index moved -1.0%.

Ryan Specialty trades -6.18% away from its average analyst target price of $47.56 per share. The 9 analysts following the stock have set target prices ranging from $39.0 to $51.0, and on average have given Ryan Specialty a rating of buy.

Anyone interested in buying RYAN should be aware of the facts below:

Ryan Specialty's current price is 576.9% above its Graham number of $6.59, which implies that at its current valuation it does not offer a margin of safety
Based on its trailing earnings per share of 0.57, Ryan Specialty has a trailing 12 month Price to Earnings (P/E) ratio of 78.3 while the S&P 500 average is 15.97
RYAN has a forward P/E ratio of 26.9 based on its forward 12 month price to earnings (EPS) of $1.66 per share
The company has a price to earnings growth (PEG) ratio of 1.75 — a number near or below 1 signifying that Ryan Specialty is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 9.94 compared to its sector average of 1.57
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers.
Based in Chicago, the company has 4,051 full time employees and a market cap of $11.6 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.